S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
The single greatest medical breakthrough of all time? (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
The single greatest medical breakthrough of all time? (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
The single greatest medical breakthrough of all time? (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
The single greatest medical breakthrough of all time? (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
The single greatest medical breakthrough of all time? (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
The single greatest medical breakthrough of all time? (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
S&P 500   4,464.05
DOW   35,281.40
QQQ   366.24
Biden and House Democrats hope to make curbing 'junk fees' a winning issue in 2024
The single greatest medical breakthrough of all time? (Ad)
Yes, inflation is down. No, the Inflation Reduction Act doesn't deserve the credit
Stock market today: Asia follows Wall Street lower after US data revive fears about rate hike
The single greatest medical breakthrough of all time? (Ad)
Illinois governor signs ban on firearms advertising allegedly marketed to kids and militants
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
The single greatest medical breakthrough of all time? (Ad)
US Steel rejects a $7.3 billion offer from rival Cleveland-Cliffs; considers alternatives
Don't expect quick fixes in 'red-teaming' of AI models. Security was an afterthought
OTCMKTS:ITEGY

Hyve Group (ITEGY) Stock Forecast, Price & News

$0.82
+0.55 (+198.55%)
(As of 03/20/2023)
Compare
Today's Range
$0.82
$0.82
50-Day Range
$0.82
$0.82
52-Week Range
$0.28
$0.82
Volume
100 shs
Average Volume
550 shs
Market Capitalization
N/A
P/E Ratio
1.49
Dividend Yield
12.78%
Price Target
N/A

ITEGY stock logo

About Hyve Group (OTCMKTS:ITEGY) Stock

As of May 22, 2023, Hyve Group Plc operates as a subsidiary of Providence Equity LLP.

ITEGY Price History

ITEGY Stock News Headlines

Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Hyve Group PLC OTC (ITEGY)
Shoptalk Announces The Shoptalk ATLIS Awards
See More Headlines
Receive ITEGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hyve Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Specialty Business Services
Sub-Industry
N/A
Current Symbol
OTCMKTS:ITEGY
Fax
N/A
Employees
560
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Mark Shashoua (Age 53)
    CEO & Exec. Director
    Comp: $1.68M
  • Mr. John Gulliver
    Chief Fin. & Operations Officer and Director
  • Mr. Grant Altson
    Chief Information Officer
  • Ms. Marina Calero
    Group Head of Investor Relations
  • Ms. Helen Kennedy Shamir Milburn
    Gen. Counsel
  • Nikki Griffiths
    Group Communications & ESG Director
  • Mr. Martin Beck
    Head of Sales
  • Mr. Robert Pfeiffer
    Chief Corp. Devel. Officer
  • Ms. Lydia Matthews
    Head of Content
  • Mr. Karin Hausmann
    Head of Lead Generation













ITEGY Stock - Frequently Asked Questions

Should I buy or sell Hyve Group stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Hyve Group in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" ITEGY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ITEGY, but not buy additional shares or sell existing shares.
View ITEGY analyst ratings
or view top-rated stocks.

How have ITEGY shares performed in 2023?

Hyve Group's stock was trading at $0.2750 at the beginning of the year. Since then, ITEGY shares have increased by 198.5% and is now trading at $0.8210.
View the best growth stocks for 2023 here
.

What is Hyve Group's stock symbol?

Hyve Group trades on the OTCMKTS under the ticker symbol "ITEGY."

How do I buy shares of Hyve Group?

Shares of ITEGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hyve Group's stock price today?

One share of ITEGY stock can currently be purchased for approximately $0.82.

How many employees does Hyve Group have?

The company employs 560 workers across the globe.

How can I contact Hyve Group?

Hyve Group's mailing address is 2 Kingdom Street, London W2 6JG, United Kingdom, . The official website for the company is www.ite-exhibitions.com. The company can be reached via phone at 442075965000.

This page (OTCMKTS:ITEGY) was last updated on 8/14/2023 by MarketBeat.com Staff

My Account -